# reload+after+2024-01-21 01:47:34.374575
address1§2015 Peel Street
address2§11th Floor
city§Montreal
state§QC
zip§H3A 1T8
country§Canada
phone§514 336 7800
fax§514 331 9691
website§https://www.theratech.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
fullTimeEmployees§144
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Paul  Lévesque', 'age': 59, 'title': 'President, CEO & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 1309983, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Philippe  Dubuc M.B.A., MBA', 'age': 56, 'title': 'Senior VP & CFO', 'yearBorn': 1967, 'fiscalYear': 2022, 'totalPay': 449759, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jocelyn  Lafond L.L.M., LL.B.', 'age': 55, 'title': 'General Counsel & Corporate Secretary', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 325861, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Christian  Marsolais Ph.D.', 'age': 60, 'title': 'Senior VP & Chief Medical Officer', 'yearBorn': 1963, 'fiscalYear': 2022, 'totalPay': 466810, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John  Leasure', 'age': 58, 'title': 'Global Commercial Officer', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 513948, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Hon. Andre  Dupras M.Sc.', 'age': 59, 'title': 'Vice President of Human Resources', 'yearBorn': 1964, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§7
boardRisk§2
compensationRisk§8
shareHolderRightsRisk§7
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.66
priceToSalesTrailing12Months§1.3999282
currency§USD
dateShortInterest§1702598400
forwardEps§-0.32
exchange§NCM
quoteType§EQUITY
shortName§Theratechnologies Inc.
longName§Theratechnologies Inc.
firstTradeDateEpochUtc§1234535400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§884fbfec-7a61-3b13-b77d-a67bfc89456f
gmtOffSetMilliseconds§-18000000
targetHighPrice§36.0
targetLowPrice§5.0
targetMeanPrice§16.75
targetMedianPrice§13.0
recommendationMean§2.2
recommendationKey§buy
numberOfAnalystOpinions§4
quickRatio§0.328
grossMargins§0.74317
ebitdaMargins§-0.10817
trailingPegRatio§None
